Literature DB >> 12981214

Acute hepatitis associated with mouse leukemia. I. Pathological features and transmission of the disease.

J B NELSON.   

Abstract

On four occasions a naturally occurring mouse leukemia, which was maintained by serial passage in weanlings of the Princeton strain, was superseded by a syndrome typical of acute hepatitis. Once initiated, the disease was regularly transmissible by the injection of liver suspensions of sick mice. It was also passed, though irregularly, by feeding such suspensions, and it also followed cannibalism. The course of the disease after intraperitoneal injection of liver suspensions into normal weanlings was commonly less than 7 days and the mortality rate nearly 100 per cent. Focal or diffuse necrosis of the liver was the only constant lesion at autopsy. On recovery, which occurred only in exceptional cases, cirrhosis was often found. The primary source of the disease was undetermined. Latent carriage by healthy mice was not detectable on direct examination nor by the serial passage of suspensions of normal livers.

Entities:  

Keywords:  HEPATITIS, INFECTIOUS; LEUKEMIA/experimental

Mesh:

Year:  1952        PMID: 12981214      PMCID: PMC2136152          DOI: 10.1084/jem.96.4.293

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  A hepatitis virus of mice.

Authors:  A W GLEDHILL; C H ANDREWES
Journal:  Br J Exp Pathol       Date:  1951-12

2.  Observations on Tyzzer's Disease in Mice.

Authors:  F L Rights; E B Jackson; C Technician; J E Smadel
Journal:  Am J Pathol       Date:  1947-07       Impact factor: 4.307

3.  A Fatal Disease of the Japanese Waltzing Mouse caused by a Spore-Bearing Bacillus (Bacillus Piliformis, N. SP.).

Authors:  E E Tyzzer
Journal:  J Med Res       Date:  1917-11
  3 in total
  16 in total

1.  The effect of a murine hepatitis virus on the liver. An anatomic and histochemical study.

Authors:  W A JONES; R B COHEN
Journal:  Am J Pathol       Date:  1962-09       Impact factor: 4.307

2.  [On the significance of virus-like agents with leukemia-inducing ability in spontaneous breast carcinoma and in transplant tumors in mice].

Authors:  F SCHMIDT
Journal:  Z Krebsforsch       Date:  1960

3.  MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY.

Authors:  F B Bang; A Warwick
Journal:  Proc Natl Acad Sci U S A       Date:  1960-08       Impact factor: 11.205

4.  Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture.

Authors:  N Hirano; K Fujiwara; S Hino; M Matumoto
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  Differential growth of MHV (PRI) and MHV (C3H) in genetically resistant C3H mice rendered susceptible by eperythrozoon infection.

Authors:  G C Lavelle; F B Bang
Journal:  Arch Gesamte Virusforsch       Date:  1973

6.  Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice.

Authors:  K Nakanaga; K Yamanouchi; K Fujiwara
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

7.  Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes.

Authors:  N Hirano; T Murakami; F Taguchi; K Fujiwara; M Matumoto
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

8.  THE APPEARANCE OF A HEPATOTROPHIC VIRUS IN MICE THYMECTOMIZED AT BIRTH.

Authors:  J EAST; D M PARROTT; F C CHESTERMAN; A POMERANCE
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

9.  AN ELECTRON MICROSCOPE STUDY OF THE DEVELOPMENT OF A MOUSE HEPATITIS VIRUS IN TISSUE CULTURE CELLS.

Authors:  J F DAVID-FERREIRA; R A MANAKER
Journal:  J Cell Biol       Date:  1965-01       Impact factor: 10.539

10.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.